Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr Hoffmann is the CEO of EPO, a CRO that provides comprehensive services for preclinical oncology research. He has specialized in preclinical and translational research and is developing personalized models to support the selection of the most appropriate drug treatment for individual patients. From 1997 to 2009 he worked as group leader in Oncology Research at Schering and Bayer. Dr. Hoffmann is member of the German Cancer Foundation and the Board of the Experimental Cancer Research Division (AEK) and the AACR. He is member of the CONELIS expert network and of the board of CPO Cellular Phenomics and Oncology.